Humacyte is engaged in the development and manufacture of off-the-shelf, universally implantable, bioengineered human tissues. Co. is utilizing its technology platform to develop proprietary, bioengineered, acellular human tissues for use in the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. We show 8 historical shares outstanding datapoints in our HUMA shares outstanding history coverage, used to compute HUMA market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing HUMA market cap history over the course of time is important for investors
interested in comparing HUMA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of HUMA versus a peer is one thing; comparing
HUMA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like HUMA can fluctuate over the course of history.
With this page we aim to empower investors researching HUMA by allowing them to research the HUMA market cap history. |
Free HUMA Email Alerts:
Video: The Importance of Market Cap
